APIS · Notes

Particle Therapy and CyberKnife SBRT: Different Roles

Particle therapy and CyberKnife stereotactic body radiation therapy (SBRT) are both local radiation treatments, but they differ in beam physics, dose distribution, motion management and the situations in which they are considered.

How They Differ

SBRT, delivered by CyberKnife and other systems, uses highly focused photon (X-ray) radiation, often for small, well-defined tumors treated in a few sessions. [1] Particle therapy uses proton or carbon-ion beams that deposit most of their dose at a set depth, with less dose beyond the target. See Proton vs Carbon-Ion Therapy.

AspectParticle therapyCyberKnife SBRT
Radiation typeProton or carbon-ion beamsPhoton (X-ray) beams
Dose beyond the targetCan be reducedExit dose remains a planning consideration
Motion managementDepends on the system and treatment siteReal-time tracking is a core feature
Typical roleSelected tumors where dose shaping or tissue sparing mattersSmall, well-defined lesions suited to stereotactic treatment

When Each May Be Considered

Particle therapy may be reviewed for tumors near organs at risk, re-irradiation, larger or irregular targets and some relatively radioresistant tumors. SBRT may suit small, well-circumscribed lesions when nearby organ dose limits can be met.

This is not a ranking. The right option depends on the cancer type, size and location, earlier treatment, organ dose limits, imaging and the patient's overall condition. Recent CT, MRI or PET-CT images in DICOM format are usually needed for planning review.

Ask Which Approach Fits Your Case

The hospital compares options after reviewing your images and records.

Sources and dates
  1. National Cancer Institute. External Beam Radiation Therapy for Cancer. Reviewed May 15, 2025.

Content reviewed November 17, 2026.

Your request has been received.
We will review the submitted information and contact you by email if additional details are required.​